|
Market Closed -
NSE India S.E.
12:05:07 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 708.60 INR | -1.96% |
|
-4.11% | +0.51% |
| 07-31 | Astec LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 04-27 | Astec LifeSciences March-quarter consol net loss 77.6 million rupees | RE |
Company Valuation: Astec LifeSciences Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,391 | 27,154 | 20,932 | 13,243 | 12,046 | 15,790 | - | - |
| Change | - | -21.04% | -22.91% | -36.73% | -9.04% | 31.08% | - | - |
| Enterprise Value (EV) | 37,163 | 27,154 | 20,932 | 13,243 | 12,046 | 15,790 | 15,790 | 15,790 |
| Change | - | -26.93% | -22.91% | -36.73% | -9.04% | 31.08% | 0% | 0% |
| P/E | 38.3x | 106x | -44.6x | -9.83x | -14.3x | -56.7x | 64.4x | 24.5x |
| PBR | 8.68x | 6.47x | 5.67x | 5.64x | - | 4.36x | 3.84x | 3.34x |
| PEG | - | -1.5x | 0x | -0x | 0.3x | 0.8x | -0x | 0x |
| Capitalization / Revenue | 5.08x | 4.32x | 4.57x | 3.47x | - | 2.82x | 2.13x | 1.74x |
| EV / Revenue | 0x | 0x | 0x | 0x | - | 2.82x | 2.13x | 1.74x |
| EV / EBITDA | 0x | 0x | -0x | -0x | - | 35.2x | 15.1x | 10.5x |
| EV / EBIT | 0x | 0x | -0x | -0x | - | 29.8x | 20.6x | 12.4x |
| EV / FCF | -0x | - | - | - | - | -89.2x | -101x | 62.9x |
| FCF Yield | -2.34% | - | - | - | - | -1.12% | -0.99% | 1.59% |
| Dividend per Share 2 | 1.5 | 1.5 | - | - | - | 1.5 | 1.25 | 1.25 |
| Rate of return | 0.09% | 0.11% | - | - | - | 0.21% | 0.18% | 0.18% |
| EPS 2 | 45.85 | 13.04 | -23.93 | -68.71 | -37.79 | -12.5 | 11 | 28.9 |
| Distribution rate | 3.27% | 11.5% | - | - | - | -12% | 11.4% | 4.33% |
| Net sales 1 | 6,766 | 6,282 | 4,582 | 3,813 | - | 5,595 | 7,409 | 9,082 |
| EBITDA 1 | 1,541 | 762.5 | -59.13 | -662.1 | - | 448 | 1,044 | 1,504 |
| EBIT 1 | 1,197 | 426 | -421.7 | -1,099 | - | 530 | 767 | 1,276 |
| Net income 1 | 898.6 | 255.6 | -469.3 | -1,348 | -809.2 | -279 | 246 | 644.5 |
| Net Debt | 2,772 | - | - | - | - | - | - | - |
| Reference price 2 | 1,755.25 | 1,385.00 | 1,067.45 | 675.25 | 540.60 | 708.60 | 708.60 | 708.60 |
| Nbr of stocks (in thousands) | 19,593 | 19,606 | 19,609 | 19,611 | 22,282 | 22,283 | - | - |
| Announcement Date | 02/05/22 | 02/05/23 | 02/05/24 | 23/04/25 | 27/04/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -56.69x | - | - | 0.21% | 164M | |
| 15x | 1.57x | 6.93x | 3.13% | 33.47B | |
| 10.57x | 3.37x | 5.81x | 3.41% | 18.81B | |
| 7.51x | 2.18x | 4.62x | 1.87% | 17.41B | |
| 16.03x | 3.74x | 9.86x | 6.13% | 14.78B | |
| 7.63x | 0.82x | 4.15x | 6.74% | 10.99B | |
| Average | 0.01x | 2.34x | 6.27x | 3.58% | 15.94B | |
| Weighted average by Cap. | 11.95x | 2.28x | 6.42x | 3.83% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ASTEC Stock
- Valuation Astec LifeSciences Limited
Select your edition
All financial news and data tailored to specific country editions
